Physician

Inder Paul Singh

According to 2025 Medicare claims, Inder Singh (NPI: 1063430023) practices ophthalmology in the Racine-Mount Pleasant, WI market, with the plurality of this provider's patient population coming from Racine, WI. This provider's primary affiliated billing organization is EYE CENTERS OF RACINE AND KENOSHA LTD (NPI: 1710905781; TIN: 391415029) and primary practice location at 53142-7583.

Singh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 493 traditional Medicare patients, billed 2,880 HCPCS/CPT codes, and received $308,443 in Medicare payments. The top billing code was 66984 (Removal of cataract with insertion of prosthetic lens). Part D data shows 2,288 prescription claims across 627 beneficiaries totaling $707,568 in drug costs, led by Xdemvy (Lotilaner). Open Payments data shows 397 records totaling $572,587. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $497,274 to $308,443. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$255K$510K2015 Medicare payment: $497,274 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $450,258 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $477,466 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $509,532 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $454,342 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $360,845 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $430,694 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $329,394 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $372,649 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $308,443 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158754,235$497,274
20168553,903$450,258
20178544,052$477,466
20188033,896$509,532
20196272,977$454,342
20204932,645$360,845
20215603,256$430,694
20224702,609$329,394
20235343,277$372,649
20244932,880$308,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$511K$1.0M2015 Drug cost: $698,326 (USD; Tot_Drug_Cst)2016 Drug cost: $699,418 (USD; Tot_Drug_Cst)2017 Drug cost: $877,561 (USD; Tot_Drug_Cst)2018 Drug cost: $937,741 (USD; Tot_Drug_Cst)2019 Drug cost: $852,676 (USD; Tot_Drug_Cst)2020 Drug cost: $909,538 (USD; Tot_Drug_Cst)2021 Drug cost: $1,021,480 (USD; Tot_Drug_Cst)2022 Drug cost: $993,622 (USD; Tot_Drug_Cst)2023 Drug cost: $858,947 (USD; Tot_Drug_Cst)2024 Drug cost: $707,568 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155883,154$698,326
20165382,840$699,418
20176263,000$877,561
20186302,918$937,741
20195832,460$852,676
20205482,519$909,538
20216052,685$1,021,480
20225642,254$993,622
20236132,340$858,947
20246272,288$707,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
66984Removal of cataract with insertion of prosthetic lens114192$313
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more123133$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more137193$50
92083Exam of visual field with extended testing111130$35
92020Exam of the internal drainage system of eye128146$16

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XdemvyLotilaner592,782$112,736
RestasisCyclosporine664,140$82,176
XiidraLifitegrast562,910$67,396
LumiganBimatoprost1137,153$58,014
IlevroNepafenac1443,930$54,699

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.319$375,114Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.78$197,473Rayner Intraocular Lenses Limited
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Inder Paul Singh?

Tedicare shows public-source Medicare data for Inder Paul Singh (NPI 1063430023), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Inder Paul Singh have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Inder Paul Singh?

Inder Paul Singh is linked to EYE CENTERS OF RACINE AND KENOSHA LTD (billing NPI 1710905781) in the available physician profile data.

Does Inder Paul Singh have Open Payments data?

Inder Paul Singh has 397 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.